NCT03450590View on ClinicalTrials.gov

Heart Rate Variability and Cardiorespiratory Complications During Ophthalmic Arterial Chemotherapy for Retinoblastoma

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
Parasympathetic Cardiovascular Function Disorder
Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03450590 - Heart Rate Variability and Cardiorespiratory Complications During Ophthalmic Arterial Chemotherapy for Retinoblastoma | Biotech Hunter | Biotech Hunter